Schizophrenia is a disorder with a heterogeneous etiology involving complex interplay
between genetic and environmental risk factors. The immune system is now known to play …

Major depressive disorder (MDD) is a psychiatric condition that affects a large number of
people in the world, and the treatment existents do not work for all individuals affected. Thus …

Depression is a debilitating mental disorder that affects> 322 million people worldwide.
Despite the availability of several antidepressant agents, many patients remain treatment …

Major depressive disorder (MDD) is a prevalent psychiatric disorder associated with varied
prognosis, chronic course, and duration of illness with reduced quality of life. One factor that …

Exposure to early adversity increases vulnerability to psychiatric disorders in later life.
Microglia-mediated inflammation has been linked to psychopathology, so such inflammation …

The putative effects of early-life stress (ELS) on later behavior and neurobiology have been
widely investigated. Recently, microglia have been implicated in mediating some of the …

The involvement of central and peripheral inflammation in the pathogenesis and prognosis
of major depressive disorder (MDD) has been demonstrated. The increase of pro …

The dynamic expansions and contractions of the microglia population in the central nervous
system (CNS) to achieve homeostasis are likely vital for their function. Microglia respond to …

Both conditions, major depressive disorder (MDD) and diabetes mellitus (DM) are chronic
and disabling diseases that affect a very significant percentage of the world's population …

Early life adversity (ELA)-which includes physical, psychological, emotional, and sexual
abuse is one of the most common predictors to diverse psychopathologies later in …